Document is current
Any future updates will be listed below
-
Authors
Clavijo Jordan, Veronica
Martins, André F.
Dao, Erica
Geraki, Kalotina
Chirayil, Sara
Wen, Xiaodong
Khalighinejad, Pooyan
Parrott, Daniel
Wang, Xiaojing
Gonzalez Pagan, Patricia
Rofsky, Neil
Farquharson, Michael
Sherry, A. Dean
-
Funding
Funding for this research was provided by:
National Institutes of Health (K22CA241387, K22CA241387)
Cancer Prevention and Research Institute of Texas (RP-180178, RP-180178, RP-180178, RP-180178, RP-180178, RP-180178, RP-180178)
- License Information
-
More Information
Article History
Received: 4 June 2024
Accepted: 4 October 2024
First Online: 6 November 2024
Competing interests
: PATENTS: A) 10,207,013 B2*2/2019 Inventors: Christian Preihs, Jing Yi, V.C.J., Yunkou Wu, Khaled Nasr, A.D.S., S.C. B) 11,097,017 B2*8/2021 Inventors: Christian Preihs, Jing Yi, V.C.J., Yunkou Wu, Khaled Nasr, A.D.S., S.C. C) 11,713,305 B2*8/2023 Inventors: A.F.M., S.C., V.C.J., A.D.S. These patents pertain to the Gd-based zinc probe used in this manuscript. All three have been licensed by VitalQuan, LLC. INDIVIDUAL CONFLICT OF INTEREST: A.D.S. is a scientific C-Founder of VitalQuan, LLC and holds founders stock. The remaining authors declare no competing interests.
